DOX - Amdocs Limited
| Previous Close | 60.83 |
| Open | 60.85 |
| Bid | 61.09 x 800 |
| Ask | 61.11 x 800 |
| Day's Range | 60.85 - 61.26 |
| 52 Week Range | 52.60 - 70.31 |
| Volume | 302,188 |
| Avg. Volume | 926,112 |
| Market Cap | 8.498B |
| Beta (3Y Monthly) | 0.45 |
| PE Ratio (TTM) | 23.80 |
| EPS (TTM) | 2.57 |
| Earnings Date | Jul 29, 2019 - Aug 2, 2019 |
| Forward Dividend & Yield | 1.14 (2.07%) |
| Ex-Dividend Date | 2019-06-27 |
| 1y Target Est | 70.57 |
- Thomson Reuters StreetEvents•10 hours ago
Edited Transcript of DOX earnings conference call or presentation 14-May-19 9:00pm GMT
Q2 2019 Amdocs Ltd Earnings Call
- Zacks•yesterday
DOX vs. NOW: Which Stock Should Value Investors Buy Now?
DOX vs. NOW: Which Stock Is the Better Value Option?
- Zacks•4 days ago
Will Amdocs to Surge Higher?
As of late, it has definitely been a great time to be an investor Amdocs.
- Zacks•5 days ago
Amdocs' Platform to Aid Sprint's IT Modernization Efforts
Amdocs' (DOX) DigitalONE platform and flexible catalogue will enable Sprint to collate large number of catalogues to one solution.
- GlobeNewswire•5 days ago
Telefónica and Amdocs Agree to Extend and Expand Multi-Year Strategic Partnership in Argentina and Chile to Accelerate their Digital Transformation
Amdocs (DOX), a leading provider of software and services to communications and media companies, and Telefónica, one of the largest telecommunications companies in the world, today announced a multi-year extension and expansion of their strategic partnership. Telefonica went to market with a fully modernized multi-play platform in Argentina supporting over 25 million customers of mobile, pre- and post-paid, broadband, fixed line, TV and OTT services.
- Motley Fool•6 days ago
Why Lyft, Beyond Meat, and Amdocs Jumped Today
Positive news on several fronts helped give stocks a boost.
- Motley Fool•6 days ago
Why Shares of Amdocs Popped Today
A mostly positive quarterly report sent the stock higher.
- Zacks•6 days ago
Amdocs (DOX) Q2 Earnings & Revenues Top Estimates, View Up
Amdocs' (DOX) fiscal Q2 results benefit from new customer gains, penetration into new regions and a number of managed services awards.
Motley Fool•6 days agoAmdocs Ltd (DOX) Q2 2019 Earnings Call Transcript
DOX earnings call for the period ending March 31, 2019.
- Zacks•7 days ago
Amdocs (DOX) Q2 Earnings and Revenues Beat Estimates
Amdocs (DOX) delivered earnings and revenue surprises of 2.91% and 0.39%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- CNBC•7 days ago
Stocks making the biggest moves after hours: Tilray, Agilent and more
Check out the companies making headlines after the bell:Shares of Tilray TLRY popped nearly 5% during extended trading Tuesday after the Canadian pharmaceutical and cannabis company reported first-quarter revenue that beat expectations.
- Associated Press•7 days ago
Amdocs: Fiscal 2Q Earnings Snapshot
On a per-share basis, the Chesterfield, Missouri-based company said it had profit of 90 cents. Earnings, adjusted for one-time gains and costs, were $1.06 per share. The results surpassed Wall Street expectations. ...
- GlobeNewswire•7 days ago
Amdocs Limited Reports Second Quarter Fiscal 2019 Results Record Quarterly Revenue of $1.02 Billion
Raises Fiscal 2019 GAAP Diluted EPS Growth Outlook to 33.0%-41.0% YoY Raises Fiscal 2019 Non-GAAP Diluted EPS Growth Outlook to 4.5%-8.5% YoY Second Quarter Fiscal 2019.
- GlobeNewswire•7 days ago
In a World of Increased Privacy Concerns, Amdocs Implements Cutting Edge Customer Privacy Solution for Sunrise
Amdocs (DOX), a leading provider of software and services to communications and media companies, has today announced the completion of a project that helps ensure the privacy of customers’ data for Sunrise, the largest private service provider in Switzerland offering mobile, fixed, broadband internet and TV services. Working with the SecuPi data-protection platform, Amdocs completed the project, covering 17 use cases across 12 systems, within just 11 weeks, enabling Sunrise to rapidly meet increasing customer expectations and regulations around cyber security and data protection. Helping to drive the quick implementation of the Amdocs and SecuPi solution at Sunrise, was the fact that this project did not require any changes to the code in Sunrise’s core systems, and is easily adaptable for the company’s future requirements.
- GlobeNewswire•7 days ago
KT Swiftly Grows Subscribers Base for One of the First 5G Commercial Services Globally, with Amdocs’ Service Monetization Solution
Amdocs (DOX), a leading provider of software and services to communications and media companies, today announced that KT Corporation, the largest quad-play service provider in South Korea, is using Amdocs’ Service Monetization and Convergent Charging solution for one of the world’s first 5G commercial services, launched recently. The future-ready Amdocs Service Monetization solution was initially deployed to support KT 4G services and is now supporting KT 5G services. As a result, KT is able to launch and monetize new and innovative services faster, accelerating the adoption and growth of 5G services.
- GlobeNewswire•7 days ago
SIEMENS and Amdocs to Offer High-reliability Connected Critical Infrastructure Wireless Solutions based on CBRS
Siemens, a global technology innovator with leading solutions for intelligent infrastructure, and Amdocs (DOX), a leading provider of software and services to communications and media companies, today announced the availability of a joint solution to enable mission-critical networks to leverage shared Citizens Broadband Radio Service (CBRS) spectrum. Spectrum is a critical, highly valued and scarce resource.
- GlobeNewswire•7 days ago
Protected.net Reduces Customer Churn and Captures Lost Revenue with Vindicia Select
With Vindicia Select, Protected.net has dramatically cut its involuntary churn rate, leading to increased retention and longer customer lifetimes. Further, because Vindicia Select’s technology automatically fixes failed transactions, customers maintain seamless and uninterrupted access to the Protected.net service. A recent Forrester Consulting study found that Vindicia Select helps companies recover significant numbers of terminally failed payment transactions, which in turn reduces pressure on billing teams, enhances customer retention rates, increases revenues, improves overall customer lifetime value and protects brand value.
- GlobeNewswire•7 days ago
Amdocs’ Cloud Native Digital Solutions to be Deployed by Sprint to Continue Transformation and Modernization of its Customer Experiences
This project is part of Sprint Chief Operating Officer Nestor Cano’s IT modernization journey to reduce operational expenditures while delivering more robust offerings, enabling quicker delivery cycles and responding more proactively to customer needs. Sprint has deployed Amdocs’ microservices development and deployment suite to efficiently and quickly deliver market offerings as well as serve as the backbone for future Sprint developments. Amdocs’ digital commerce (DigitalONE) and flexible catalogue allows Sprint to reduce the large number of catalogues to one unified solution, enabling quicker delivery of more offerings combined with significant operational efficiencies.
- GlobeNewswire•7 days ago
Amdocs Supports Capita Business Services Ltd. in Building-on the Successful Congestion Charge Program and Roll Out for Transport for London’s Ultra-Low Emission Zone (ULEZ)
Amdocs (DOX), a leading provider of software and services to communications and media companies, today revealed that it has extended its partnership with Capita Business Services, a leading provider of technology enabled business services, to deliver significant elements of the technology, testing and professional services that supported the rollout of Transport for London’s new Ultra-Low Emission Zone (ULEZ) regulations and standards, which launched on April 8th 2019. The ULEZ replaces the existing emissions surcharge (the ‘T-charge’), so that vehicles travelling in central London will now have to meet new, tighter emissions standards, or pay a daily charge.
- ACCESSWIRE•7 days ago
Amdocs Ltd. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 14, 2019 / Amdocs Ltd. (NASDAQ: DOX ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on May 14, 2019 at 5:00 PM Eastern Time. ...
Yahoo Finance•9 days agoWalmart earnings, retail sales – What to know in the week ahead
Another wave of earnings reports and economic data releases will try to pull focus from the concerns of escalating trade tensions that weighed on markets last week.
- Simply Wall St.•11 days ago
Do You Know What Amdocs Limited's (NASDAQ:DOX) P/E Ratio Means?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
- Zacks•14 days ago
Amdocs (DOX) Earnings Expected to Grow: Should You Buy?
Amdocs (DOX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- ACCESSWIRE•20 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amdocs Limited - DOX
NEW YORK, NY / ACCESSWIRE / May 1, 2019 / Pomerantz LLP is investigating claims on behalf of investors of Amdocs Limited ("Amdocs" or the "Company") (DOX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether Amdocs and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- GuruFocus.com•24 days ago
Stocks That Fell to 3-Year Lows in the Week of April 26
Bristol-Myers Squibb Company (BMY), Walgreens Boots Alliance Inc. (WBA), CenturyLink Inc. (CTL) and Amdocs Ltd. (DOX) have declined to their three-year lows. The prices of Bristol-Myers Squibb Company (BMY) shares have declined to $45.89, which is only 3.5% above the 3-year low of $44.30. Bristol-Myers Squibb Company is an American international pharmaceutical company that manufactures prescription pharmaceuticals in various therapeutic areas including cancer, cardiovascular diseases, diabetes, hepatitis, and HIV.
